Home |
Free Dividend Report |
Stock Splits Calendar |
ARCT Stock Split History |
Preferred Stock Newsletter |
ARCT Options Chain |
Stock Message Boards |
Arcturus Therapeutics Holdings (ARCT) has 1 split in our Arcturus Therapeutics Holdings stock split history database. The split for ARCT took place on November 16, 2017. This was a 1 for 7 reverse split, meaning for each 7 shares of ARCT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.
When a company such as Arcturus Therapeutics Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Arcturus Therapeutics Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arcturus Therapeutics Holdings shares, starting with a $10,000 purchase of ARCT, presented on a split-history-adjusted basis factoring in the complete Arcturus Therapeutics Holdings stock split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/06/2014 | |
End date: | 05/02/2024 | |
Start price/share: | $117.67 | |
End price/share: | $26.52 | |
Dividends collected/share: | $0.00 | |
Total return: | -77.46% | |
Average Annual Total Return: | -13.85% | |
Starting investment: | $10,000.00 | |
Ending investment: | $2,252.84 | |
Years: | 10.00 |
About Arcturus Therapeutics Holdings |
Arcturus Therapeutics Holdings is a clinical -stage messenger RNA medicines and vaccine company focused on the development of infectious disease vaccines and other opportunities within liver and respiratory rare diseases. Co.'s initial COVID-19 vaccine candidate, ARCT-021, was designed to promote immune responses to the spike protein of the Severe Acute Respiratory Syndrome-2 virus, which is the part of the virus that allows infection to occur. The LUNAR-OTC development program addresses ornithine transcarbamylase (OTC) deficiency, a genetic disease caused by mutations in the OTC gene that lead to dysfunctional or deficient OTC. The LUNAR-CF program addresses cystic fibrosis lung disease. According to our Arcturus Therapeutics Holdings stock split history records, Arcturus Therapeutics Holdings has had 1 split. |
ARCT Split History Table | |
Date | Ratio |
11/16/2017 | 1 for 7 |
Healthcare Stock Splits |
ARCT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
ARGS Split History Also explore: ARCT shares outstanding history
Free ARCT Email Alerts:
|
Arcturus Therapeutics Holdings Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.